Using a combination of DPP-4 inhibitors, a second and/or a third type of diabetic formulation can be selected for therapeutic purposes from gloves, endosulfan, fipronil, glycerin, alpha-glucose inhibitors a, GLP-1 and insulin. Or type 2 diabetes.
DUGI, KLAUS,MARK, MICHAEL,GRAEFE-MODY EVA ULRIKE,WOERLE, HANS-JUERGEN,ZIMDAHL-GELLING, HEIKE.
申请号：
CL2012001337
公开号：
CL2012001337A1
申请日:
2012.05.23
申请国别(地区):
CL
年份:
2012
代理人:
摘要：
Composition or Pharmaceutical Combination comprising (a) a dpp-4 inhibitor and Optionally, (b) a Second diabetic agent which consists of Thiazolidinediones, sulfonylureas, Biguanides, among others.And (c) a Third Agent diabetic； method to prevent or treat a disorder such as diabetes mellitus Type 1 or 2, among others.<；p>；Composició；n o combinació；n farmacé；utica que comprende a) Un inhibidor de DPP-4 y opcionalmente b) Un segundo agente diabé；tico que consiste en biguanidas, tiazolidindionas, sulfonilureas, entre otros, y c) Un tecer agente diabé；tico； mé；todo para prevenir o tratar un trastorno como la diabetes mellitus tipo 1 o 2, entre otros.<；/p>；
